Jim Simons’s Profound Medical PROF Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$67.9K Buy
+11,700
New +$79.5K ﹤0.01% 3055
2025
Q1
– Sell
-58,200
Closed -$437K – 3762
2024
Q4
$437K Sell
58,200
-700
-1% -$5.38K ﹤0.01% 2908
2024
Q3
$469K Buy
+58,900
New +$532K ﹤0.01% 2821
2024
Q2
– Sell
-18,700
Closed -$160K – 3871
2024
Q1
$160K Sell
18,700
-3,200
-15% -$26.7K ﹤0.01% 3277
2023
Q4
$186K Buy
+21,900
New +$208K ﹤0.01% 3155
2021
Q3
– Sell
-15,900
Closed -$260K – 3763
2021
Q2
$260K Sell
15,900
-58,780
-79% -$1.09M ﹤0.01% 3184
2021
Q1
$1.5M Sell
74,680
-3,600
-5% -$86.3K ﹤0.01% 2407
2020
Q4
$1.61M Sell
78,280
-57,900
-43% -$1.07M ﹤0.01% 2259
2020
Q3
$2.4M Buy
136,180
+23,300
+21% +$370K ﹤0.01% 2028
2020
Q2
$1.91M Sell
112,880
-7,300
-6% -$92.1K ﹤0.01% 2209
2020
Q1
$1.16M Buy
120,180
+107,280
+832% +$1.39M ﹤0.01% 2355
2019
Q4
$147K Buy
+12,900
New +$119K ﹤0.01% 3255

Other funds holding PROF

Jim Simons's PROF Position: Q3 2026 in Review

Jim Simons opened a new position in Profound Medical (PROF) in Q3 2026: 11,700 shares worth $67.9K. The stake represents ﹤0.01% of the portfolio and ranks #3055 among its holdings. This is a return to the name: Jim Simons previously reported a position in PROF as recently as Q4 2024.

Jim Simons first reported a position in PROF in Q4 2019 and has held it in 12 quarters since. The position peaked at $2.4M in Q3 2020. 43 funds tracked by Wall St. Rank hold PROF as of Q3 2026.

  • Jim Simons held 11,700 shares of Profound Medical worth $67.9K as of Q3 2026.
  • Profound Medical was a new Jim Simons position in Q3 2026.
  • Profound Medical made up ﹤0.01% of Jim Simons's portfolio in Q3 2026, its #3055 holding.
  • Jim Simons first reported a position in Profound Medical in Q4 2019 and has held it in 12 quarters since.
  • Jim Simons's Profound Medical position peaked at $2.4M in Q3 2020.
  • 43 funds tracked by Wall St. Rank held Profound Medical as of Q3 2026.

Based on Renaissance Technologies's 13F filing for Q3 2026, filed 12 Nov 2026.